“In addition to aspects of compound management, the University of Nottingham has accessed BioFocus’ expertise in computational chemistry to aid compound selection,” said Scott Synder, Compound Focus General Manager. “The agreement not only demonstrates our ability to perform compound management on a global scale but also to integrate other aspects of the BioFocus offering to help achieve our clients’ objectives.”
Professor Peter Fischer, Director of the Centre for Biomolecular Sciences at the University of Nottingham commented: “In the first instance we sought to acquire a base collection as a maximally diverse subset of the vast number of screening compounds available from commercial sources. After considering a number of procurement options, we chose to work with BioFocus, which combines leading expertise in both chemoinformatics and in compound management, to assemble this base collection for us.”
The newly-established Managed Chemical Compound Collection (MCCC) represents a cornerstone of the University of Nottinghams’ Drug Discovery Priority Group, which integrates diverse activities across the University aimed at translating new insights in basic biomedical science into new drugs. The University has made a major investment to provide a fully integrated and automated compound storage and handling infrastructure that underpins the MCCC. The longer-term aim for the MCCC is to provide an efficient and diverse compound screening resource for researchers at the University, as well as partners in academia and industry.